Aeovian Pharmaceuticals Company
Aeovian Pharmaceuticals aims to discover, develop, and commercialize therapeutics for the treatment of rare and age-related diseases.
Total Funding:
37000000
Headquarters:
San Francisco, California, United States
Funding Status:
Early Stage Venture
Employee Number:
1-10
Estimated Revenue:
$1M to $10M
Last Funding Type:
Series A
Number Of Exists:
Series A
Technology:
NeuroTech
Investor Type:
Early Stage Venture
Last Funding Date:
2019
Investors Number:
4
Founded Date:
2012
Industry:
Biopharma, Biotechnology, Health Care, Pharmaceutical